Compare Aurora Cannabis Inc (ACB) vs United Microelectronics Corp (UMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aurora Cannabis Inc vs United Microelectronics Corp — how do they compare? Aurora Cannabis Inc trades at $3.49 (market cap $178.92M), while United Microelectronics Corp trades at $19.39 (market cap $47.80B). The key difference: United Microelectronics Corp is far larger — about 267.2× Aurora Cannabis Inc's market cap, and United Microelectronics Corp pays a 2.13% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.
| ACB | UMC | |
|---|---|---|
Market Cap | $178.92M | $47.80B |
Sector | Health | Technology |
52-Week High | $6.23 | $28.02 |
52-Week Low | $2.58 | $6.58 |
Enterprise Value | $123.48M | $44.92B |
Dividend Yield | — | 2.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $2.99, up 0.34% with a bullish technical signal despite mixed earnings. The company achieved record annual medical cannabis revenue growth of 18% YoY to $288.6 million in FY2026, but faces margin pressure from Canadian reimbursement changes. Recent Q1 2027 earnings beat expectations with $0.04 EPS versus -$0.13 estimate, though revenue declined to $67.6 million. The stock shows strong institutional support with shareholder approval of board measures and EU-GMP certification for international expansion.
ACB presents a high-risk opportunity with significant volatility. While international medical cannabis growth and operational improvements provide upside potential, persistent net losses, negative ROE/ROA, and Canadian market challenges create substantial headwinds. Analyst consensus remains cautious with only 21% buy ratings, reflecting concerns about profitability timeline and competitive pressures in the evolving cannabis sector.
UMC trades at $18.72, down 2.5% today, amid a bearish technical signal with key resistance at $19. The company reported strong Q2 2026 earnings, beating EPS estimates with $0.54 vs. $0.16 expected, and announced fab expansions in Singapore and Taiwan to meet AI-driven demand. Revenue growth is projected to rise to $250.7B in 2026, with a net income margin of 32.75%, though profit margins have declined from 2022 peaks. Analyst sentiment is mixed, with 26.7% buy ratings but a majority hold consensus.
The outlook for UMC is cautiously optimistic, driven by AI expansion and solid profitability, but risks include competitive pressures and margin compression. Near-term price action hinges on breaking resistance at $19, with support at $18. Institutional activity shows mixed positioning, reflecting uncertainty over execution amid capital expenditure increases.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →
